Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Regional heterogeneity of glioblastoma upon single-cell RNA sequencing

ABSTRACT: Regional heterogeneity of glioblastoma upon single-cell RNA sequencing

PROVIDER: PRJNA796656 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17594203.fastq.gz	Fastqsanger.gz
	SRR17594204.fastq.gz	Fastqsanger.gz
	SRR17594205.fastq.gz	Fastqsanger.gz
	SRR17594206.fastq.gz	Fastqsanger.gz
	SRR17594207.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Transcriptomic consequence of Fyn knock-out in glioblastoma, and regional heterogeneity of glioblastoma upon single-cell RNA sequencing

Project description:Transcriptomic consequence of Fyn knock-out in glioblastoma, and regional heterogeneity of glioblastoma upon single-cell RNA sequencing

| PRJNA796648 | ENA

Regional heterogeneity of glioblastoma upon single-cell RNA sequencing

Project description:Using spontaneous mouse GBM model, regional dissection of cortical margin, callosal margin, and tumor center was done for single-cell RNA sequencing to investigate molecular characteristics of marginal cancer cells.

2022-01-15 | GSE188772 | GEO

Topographic mapping of the glioblastoma proteome reveals a triple axis model of intra-tumoral heterogeneity

Project description:Glioblastoma (GBM) is an aggressive form of brain cancer with well-established patterns of intra-tumoral heterogeneity implicated in treatment resistance, recurrence and progression. While regional and single cell transcriptomic variations of GBM have been recently resolved, downstream phenotype-level proteomic programs have yet to be assigned to specific niches. Here, we leverage mass spectrometry to spatially align abundance levels of 4,794 proteins to GBM’s hallmark histomorphologic niches across 20 patients and define distinct molecular programs operational within these regional tumor compartments. Using machine learning, we overlay concordant transcriptional information, and define two distinct proteogenomic programs, MYC- and KRAS-axis hereon, that cooperate with hypoxia to produce a tri-dimensional model of intra-tumoral heterogeneity. Importantly, we show using multiple cohorts, that GBMs with an enhanced KRAS component harbor a more clinically aggressive and infiltrative phenotype. Conversely, tumor cells enriched along the MYC axis where mutually exclusive and had a distinct proliferative program. Moreover, by applying both experimental and computational approaches to link each of these distinct molecular axes with potential pharmacological therapies, we highlight differential drug sensitivities and a notable relative chemoresistance in GBM cell lines with enhanced KRAS programs. Importantly, pharmacological differences were less evident when using traditional expression-based subgroups supporting thattopographic phenotypic mapping ofGBM, and the proposed axes may provide new insights for targeting heterogeneity and overcoming therapy resistance in this aggressive disease.

2021-11-02 | PXD029290 | Pride

GNPS - Quantifying Cell Heterogeneity and Subpopulations Using Single Cell Metabolomics

Project description:We combined the Single-probe single cell MS(SCMS) experimental technique with a bioinformatics software package, SinCHet-MS (Single Cell Heterogeneity for Mass Spectrometry), to characterize changes of tumor heterogeneity, quantify cell subpopulations, and prioritize the metabolite biomarkers of each subpopulation.

2023-06-15 | MSV000092178 | GNPS

Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity

Project description:Single cell derived clones were extracted from four glioblastoma tumors using fluorescence activated cell sorting with CD15 and CD133 markers. Unsorted bulk tumors were also derived. Gene expression analysis of clones of tumor GBM-482 involved comparison between TMZ resistant (n=5) and sensitive (n=2) clones.

2015-01-03 | E-MTAB-2693 | biostudies-arrayexpress

Metabolic heterogeneity in Glioblastoma

Project description:2 cell populations [slow and fast-cycling cells] were isolated from 3 different patient-derived glioblastoma stem cell lines [L0, L1, L2].

2015-03-24 | ST000248 | MetabolomicsWorkbench

Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity

Project description:Single cell derived clones were extracted from four glioblastoma tumors using fluorescence activated cell sorting with CD15 and CD133 markers. Unsorted bulk tumors were also derived. Genotyping and copy number analysis was carried out for each tumor separately. Patient blood was used as control for three tumors while the fourth tumor had no blood available and a control cohort of 226 individuals was used for the latter (see Silversides, C.K., et al., Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS genetics, 2012. 8(8): p. e1002843.)

2015-01-03 | E-MTAB-2694 | biostudies-arrayexpress

An anatomic proteomic atlas of human glioblastoma

2021-11-02 | PXD019381 | Pride

Multiplex mapping of chromatin accessibility and DNA methylation within targeted single molecules identifies epigenetic heterogeneity in neural stem cells and glioblastoma

Project description:Human tumors are comprised of heterogeneous cell populations that display diverse molecular and phenotypic features. To examine the extent to which epigenetic differences contribute to intratumoral cellular heterogeneity, we have developed a high-throughput method, termed MAPit-patch. The method uses multiplexed amplification of targeted sequences from sub-microgram input quantities of genomic DNA followed by next generation bisulfite sequencing. This provides highly scalable and simultaneous mapping of chromatin accessibility and DNA methylation on single molecules at high resolution. Long sequencing reads from targeted regions maintains the structural integrity of epigenetic information and provides substantial depth of coverage, detecting for the first time minority subpopulations of epigenetic configurations formerly obscured by existing genome-wide and population-ensemble methodologies. Analyzing a cohort of 71 promoters of genes with exons commonly mutated in cancer, MAPit-patch uncovered several differentially accessible and methylated promoters that are associated with altered gene expression between neural stem cell (NSC) and glioblastoma (GBM) cell populations. Additionally, substantial epigenetic heterogeneity was observed across the sequenced molecules at individual promoters, indicating the presence of epigenetically distinct cellular subpopulations. This study includes 4 samples, NSC probed with 100U M.CviPI and 0U control; GBM probed with 100U M.CviPI and 0U control.

2013-10-03 | E-GEOD-50047 | biostudies-arrayexpress

Single Cell Analysis of Chromatin Accessibility Reveals Genetic and Regulatory Heterogeneity in Glioblastomas

Project description:Intra-tumoral heterogeneity is a key contributor to therapeutic failure in glioblastomas, the most common form of primary adult brain cancer. To better define this heterogeneity, genome-wide chromatin accessibility and transcription profiles of clinical glioblastoma specimens were analyzed at single cell resolution. These profiles afforded resolution of intra-tumoral genetic heterogeneity and delineation of sub-populations characterized by focal DNA amplifications including extrachromosomal circular DNA (ecDNA) that harbor highly transcribed oncogenes. The maps of open chromatin helped define cellular states of distinct tumor cell populations characterized by unique regulatory landscapes. Unexpectedly, the diverse tumor cellular states share a common regulatory program involving the Nuclear Factor 1 transcription factors (NFIA and NFIB). Silencing of these genes suppressed glioblastoma growth in vitro and in vivo. These results demonstrate opportunities for glioblastoma therapeutic discovery through integration of single nuclear profiling platforms.

2021-01-19 | GSE165037 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data